The shortage was sparked by shutting down a Canadian reactor, the source of half the U.S. supply of molybdenum-99, for repairs from May 2009 to Aug. 2010. During that time, wait times for procedures increased and patients were being turned down, said a molecular imaging expert at Siemens Healthcare.
The shortage also led some imaging facilities to turn to technologies like SPECT and SPECT/CT, which reduce isotope consumption through ultrafast imaging. Some facilities have even experimented with reducing doses during scans to determine whether they could provide the same quality.
Read the DOTmed report on isotopes for imaging.
Related Articles on Isotopes for Imaging:
5 Points on the Market for Nuclear Medicine Equipment
Covidien Signs Definitive Agreement to Sell U.S. Radiopharmacies to Triad Isotopes
Siemens Wins FDA Nod for Simultaneous PET-MRI Device
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.